Category Archives: Clinical Accelerator

Clinical Accelerator announces collaboration with CryoTherapuetics – a medical device company focused on treating coronary artery disease

Clinical Accelerator, a full-service, medical device focused contract research organization, is pleased to announce a new partnership with CryoTherapeutics – an early-stage European medical device company which has developed a novel cryoenergy therapy for the treatment of inflamed atherosclerotic plaque, … Continue reading

Posted in Cardiology, Clinical Accelerator, Medical Devices | Leave a comment

Clinical Accelerator announces collaboration with Deerfield Catalyst, a medtech incubator committed to developing transformational solutions to improve patient outcomes and streamline care

Clinical Accelerator, a full-service, medical device focused contract research organization, is pleased to announce a collaboration with Deerfield Catalyst. The company combines the resources of two established health pioneers: Coridea, a New-York based, premier Medical Device Incubator; and Deerfield, an … Continue reading

Posted in Clinical Accelerator, Medical Devices | Leave a comment

AtriAN Medical’s Clinical Data Highlighted at the 2022 AF Symposium

Pioneering cardiac autonomic pulsed field ablation (PFA) technology provides a unique option for enhancing the durability of AF ablation. GALWAY, Ireland, Jan. 17, 2022 /PRNewswire/ — Irish medical device company AtriAN Medical today announced that clinical data from it’s first-in-human study was presented … Continue reading

Posted in Cardiology, Clinical Accelerator, Conferences, Medical Devices | Leave a comment

Clinical Accelerator announces collaboration with InterVene for developing an endovascular device for deep vein valve failure

Clinical Accelerator is pleased to announce that is has begun a collaboration with InterVene, to run an early human feasibility study (EHFS) on their novel endovascular device – BlueLeaf Endovenous Valve Formation System – for deep vein valve failure. Currently, … Continue reading

Posted in Cardiology, Clinical Accelerator, Medical Devices | Leave a comment

Clinical Accelerator collaborates with Metavention on a study of a novel medical device for hypertension

Clinical Accelerator and Metavention have recently entered into a collaboration allowing Clinical Accelerator to join the program of feasibility studies already under way in the United States, New Zealand and Australia. Our organization will participate in the renal denervation trial … Continue reading

Posted in Cardiology, Central and Eastern Europe, Clinical Accelerator, Medical Devices | Tagged , , , | Leave a comment

Clinical Accelerator receives ISO 9001:2015 quality certification

Clinical Accelerator has reached a new milestone by being awarded the ISO 9001:2015 certification. The 2015 edition of ISO 9001, created by the International Organization Standardization (ISO), provides the latest standards that must be followed in order to demonstrate the … Continue reading

Posted in Clinical Accelerator | Leave a comment

Replicor publishes its REP 301-LTF study achieving durable functional cure of HDV and HBV, inactivation of cccDNA and elimination of integrated HBV DNA

Below, we are re-publishing with permission the press-release issued by Replicor Inc. on November 16, 2020 MONTREAL, November 16th, 2020 – Replicor Inc., a privately held biopharmaceutical company targeting functional cure for patients with chronic hepatitis B and D infection, … Continue reading

Posted in Biotech, Central and Eastern Europe, Clinical Accelerator | Tagged , , , , | Leave a comment

Clinical Accelerator announces collaboration with Noxopharm to advance idronoxil (NOX66), a novel treatment for COVID-19

Clinical Accelerator is pleased to announce a new collaboration with Noxopharm, a leading Australian drug development company. Noxopharm’s NOX66 therapy has received trial approval and is now in a Phase Ib, open-label trial by Clinical Accelerator in Eastern Europe. The … Continue reading

Posted in Biotech, Central and Eastern Europe, Clinical Accelerator | Leave a comment

Axon Therapies Announces Positive Results From First-In-Human Clinical Study in Late-Breaking Clinical Trial Session At 2020 Virtual HFSA Conference

Below, we are re-publishing with permission the press-release issued by Axon Therapies, Inc. on October 09, 2020 Satera™ Ablation System demonstrates success as a frontline treatment of heart failure NEW YORK, Oct. 9, 2020 /PRNewswire/ — Axon Therapies, a Coridea portfolio company focused … Continue reading

Posted in Cardiology, Central and Eastern Europe, Clinical Accelerator, Medical Devices | Leave a comment

Sequana Medical announces strong interim results from RED DESERT alfapump® DSR study and provides business update

Below, we are re-publishing with permission the press-release issued by Sequana Medical on October 22, 2020 RED DESERT: Results from first five patients indicate repeated dose alfapump DSR therapy to be safe and effective Interim data support DSR hypothesis: kidneys … Continue reading

Posted in Central and Eastern Europe, Clinical Accelerator, Medical Devices | Tagged | Leave a comment